Maria, my oncology nurse, inspired lasting change in my life through compassion, wisdom and faith during my cancer surgery ...

IDH inhibitors are now approved by the Food and Drug Administration (FDA) and are available for patients with lower-grade gliomas, offering a therapeutic option with a more manageable side effect ...

Fifteen years after being diagnosed with small lymphocytic lymphoma, I’ve found healing and meaning in the work I love and ...

EPA Deregulation Means More Air Pollution and More Cancer Deaths ...

Dr. Andrew M. Evens discussed the importance of differentiating AYA cancers from other age groups, specifically focusing on ...

Kathleen Shuey provides critical support and guidance in oncology nursing, leveraging over 25 years of experience. She ...

After my breast cancer treatment, I started a clothing bank to give others free access to recovery items like post-surgery ...

I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact ...

Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her ...

SCLC, first-line maintenance therapy with Zepzelca plus Tecentriq led to improvements in PFS and OS versus Tecentriq alone.

Proton therapy may reduce urinary, bowel and sexual side effects in prostate cancer by minimizing radiation exposure to ...

The FDA'S ODAC has casted their votes on the use of certain treatments in both the relapsed/refractory DLBCL and myeloma ...